Hericium erinaceus 'Sitake'

Hericium erinaceus 'Sitake' is a cultivated strain of lion's mane mushroom containing hericenones and erinacines, bioactive compounds studied for their potential to stimulate nerve growth factor (NGF) synthesis. As a named cultivar, its nutritional profile — including 22% protein and 8% dietary fiber — has been characterized, though strain-specific clinical evidence remains absent.

Origin & History

Hericium erinaceus, commonly known as lion's mane mushroom, is a tooth fungus native to North America and Eurasia that grows on hardwoods as a saprophyte on dead trees. It produces large, irregular bulbous fruiting bodies (5–40 cm in diameter) with distinctive crowded, hanging spines.

Historical & Cultural Context

The research notes that H. erinaceus is used in traditional Chinese medicine but provides no details about specific applications or historical duration of use. It is valued in gourmet cuisine for its crab-like or lobster-like flavor.

Health Benefits

• No clinical health benefits can be verified from the provided research
• Traditional Chinese medicine use is mentioned but without specific applications (evidence quality: traditional use only)
• Contains 22% protein and 8% dietary fiber based on nutritional analysis (evidence quality: compositional data only)
• Young specimens are preferred for culinary use with crab-like flavor (evidence quality: culinary observation)
• Safety in supplement form remains unproven according to available sources (evidence quality: safety warning)

How It Works

Erinacines, diterpenoid compounds found in the mycelium of Hericium erinaceus strains, are small enough to cross the blood-brain barrier and are hypothesized to upregulate NGF mRNA expression via activation of the TrkA receptor pathway. Hericenones, isolated from the fruiting body, may independently stimulate NGF secretion from astrocytes and peripheral nerve cells. Whether the Sitake cultivar produces these compounds at meaningfully different concentrations compared to wild-type or other cultivated strains has not been established in published research.

Scientific Research

No clinical trials, meta-analyses, or PMIDs were found in the provided research. The research explicitly states that medicinal effectiveness, safety in supplements, and active compounds are unproven.

Clinical Summary

No clinical trials have been conducted specifically on the Hericium erinaceus 'Sitake' cultivar, making it impossible to attribute strain-specific health outcomes to this variety. General Hericium erinaceus research includes a small double-blind placebo-controlled trial (n=30) in Japanese adults with mild cognitive impairment showing improved cognitive scores at 3g/day of dried fruiting body over 16 weeks, though effects reversed after cessation. Additional small trials have explored anxiety, depression, and peripheral nerve regeneration with mixed results and methodological limitations including small sample sizes and short durations. The Sitake strain's nutritional data — 22% protein and 8% dietary fiber — is derived from compositional analysis rather than intervention studies.

Nutritional Profile

Macronutrients (per 100g dry weight): Protein 22%, Dietary fiber 8%, with remaining composition comprising carbohydrates and low fat content typical of Hericium species. Protein fraction contains all essential amino acids with notable concentrations of glutamic acid and aspartic acid. Bioactive compounds include hericenones (C-E, identified in fruiting body) and erinacines (A-I, identified in mycelium), both classified as cyathane diterpenoids and aromatic compounds respectively; erinacines show higher CNS bioavailability due to blood-brain barrier permeability. Beta-glucans (specifically beta-1,3 and beta-1,6 glucans) present as primary polysaccharide fraction, functioning as prebiotic dietary fiber with moderate fermentability in the gut. Mineral content includes potassium, phosphorus, zinc, and iron at concentrations comparable to other edible Hericium species. B-vitamin complex present including riboflavin (B2) and niacin (B3); ergosterol (provitamin D2 precursor) present and converts to vitamin D2 upon UV exposure, concentration dependent on light exposure during cultivation. Bioavailability note: Polysaccharide and hericenone bioavailability is enhanced by cooking or hot-water extraction; raw consumption yields lower absorption of key bioactive fractions. Compositional data is based on nutritional analysis of the ingredient as documented; specific micronutrient concentrations for this particular cultivar ('Sitake') have not been independently verified beyond the 22% protein and 8% fiber figures provided.

Preparation & Dosage

No clinically studied dosage ranges are available in the provided research. The mushroom is consumed as food in gourmet cooking, with young specimens preferred. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified in provided research

Safety & Interactions

Hericium erinaceus is generally regarded as well-tolerated in adults, with adverse events in trials typically limited to mild gastrointestinal discomfort such as nausea or bloating. Rare case reports exist of allergic reactions, including respiratory symptoms and skin rashes, particularly in individuals with mold or mushroom allergies, suggesting caution in this population. No well-documented drug-drug interactions have been established, though theoretical concern exists around additive effects with anticoagulants such as warfarin due to platelet aggregation modulation observed in preclinical studies. Safety data during pregnancy and lactation is insufficient, and use is not recommended in these populations without medical supervision.